Hector E. Castro J.

About Hector E. Castro J.

Senior health policy and systems expert with more than two decades of experience in helping to close the gap between evidence, health policy and practice. Passionate about global health research and knowledge transfer aimed at improving equitable access to healthcare and technologies.Medical Doctor; Doctor of Public Health and Policy/ Health Economics from the University of London (London School of Hygiene & Tropical Medicine-LSHTM); MSc in Health Policy, Planning and Financing (London School of Economics & Political Science-LSE); MSc in Occupational Health, and Specialist in Health Management. Former Takemi postdoctoral fellow at the Harvard School of Public Health.>25 year experience previous senior positions include, as executive director; regional head; global practice lead, senior technical director; member of the board; scientific advisor; senior consultant and research fellow, providing technical assistance and cooperation in the fields of regulatory systems strengthening; healthcare quality management; strategic planning and purchasing; healthcare provision; health financing; health technology assessment; innovative financing; pharmaceutical policy; pricing; reimbursement; affordability policies; sustainable access to health technologies; health sector reforms; infectious; neglected; rare and non-communicable diseases; technology and knowledge transfer; and strategic information for health. Academic and research background in health policy and economics. Served as senior public officer and policy maker, and worked for public, mixed, non profit, international and private organizations. Geographical expertise includes Western and Eastern Europe, the Middle East, Africa, Asia, Latin and North America. Global health and development experience includes working with donors and development partners including USAID, PEPFAR, the Gates Foundation, Rockefeller Foundation, The WHO/PAHO, The World Bank, The Inter-American Development Bank, UNDP, DFID, GHIT (Japan), etc.Previous collaboration with research and development big pharmaceutical companies include Astellas, AstraZeneca, Bayer, BMS, Genentech, Gilead, J&J, Novartis, Pfizer, Roche, Sanofi, etc. Academic interest in Health Systems and Policies, Health Economics and Financing, Evidence Informed Policy and Practice, Health Technology Assessment (methods, processes and agencies), Managed Entry Agreements (MEAs), Health Diplomacy and Global/Public Health. Worked as lecturer and professor at world class academic institutions in different countries.

Experience

1. Health Technology Assessment International (Htai)

   Health Technology Assessment International Htai

   Present

Education

• Harvard T.H. Chan School of Public Health

  Postdoctoral Fellow, Public Health & Policy

  2015 — 2016

• University of Miami Miller School of Medicine

  Internship, Medicine & Surgery

• Universidad del Rosario

  BSc, Medicine and Surgery

  1990 — 1996

• Columbia Business School

  Certificate in Business Excellence (CIBE), Business Administration and Management, General

• London School of Hygiene and Tropical Medicine, U. of London

  Doctorate, Public Health & Policy

  2010 — 2014

• Universidad del Valle (CO)

  MSc, Occupational Health

  1999 — 2006

• Universidad Icesi

  PGD, Health Management

  2002 — 2004

• The London School of Economics and Political Science (LSE)

  MSc, Health Policy, Planning and Financing

  2009 — 2010

• London School of Hygiene and Tropical Medicine, U. of London

  MSc, Health Policy Planning and Financing

  2009 — 2010